SEC 13F Intelligence

Deerfield Management Company, L.P. / COGT

Deerfield Management Company, L.P.’s Cogent Biosciences Inc Position

Does Deerfield Management Company, L.P. own Cogent Biosciences Inc (COGT)? Yes9.04M shares worth $348M (+4.11% of its 13F portfolio) as of Q1 2026.

Position Value
$348M
Q1 2026
Shares
9.04M
% of Portfolio
+4.11%
Quarters Held
22
currently held

Position History COGT

Reported value by quarter
Q4 ’20: $11MQ4 ’20Q1 ’21: $9MQ2 ’21: $13MQ3 ’21: $13MQ3 ’21Q4 ’21: $14MQ1 ’22: $12MQ2 ’22: $53MQ2 ’22Q3 ’22: $44MQ4 ’22: $34MQ1 ’23: $32MQ1 ’23Q2 ’23: $40MQ3 ’23: $11MQ4 ’23: $6MQ4 ’23Q1 ’24: $10MQ2 ’24: $32MQ3 ’24: $40MQ3 ’24Q4 ’24: $21MQ1 ’25: $16MQ2 ’25: $19MQ2 ’25Q3 ’25: $130MQ4 ’25: $321MQ1 ’26: $348MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.04M$348M+4.11%
Q4 20259.04M$321M+4.10%
Q3 20259.05M$130M+1.98%
Q2 20252.64M$19M+0.34%
Q1 20252.63M$16M+0.31%
Q4 20242.63M$21M+0.39%
Q3 20243.74M$40M+0.60%
Q2 20243.74M$32M+0.53%
Q1 20241.53M$10M+0.18%
Q4 20231.09M$6M+0.12%
Q3 20231.09M$11M+0.23%
Q2 20233.37M$40M+0.85%
Q1 20232.97M$32M+0.71%
Q4 20222.97M$34M+0.71%
Q3 20222.97M$44M+0.88%
Q2 20225.88M$53M+1.09%
Q1 20221.60M$12M+0.27%
Q4 20211.60M$14M+0.29%
Q3 20211.60M$13M+0.26%
Q2 20211.60M$13M+0.23%
Q1 20211.00M$9M+0.18%
Q4 20201.00M$11M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deerfield Management Company, L.P.’s full portfolio or all institutional holders of COGT.